Parallel traders express concerns over industry's counterfeiting pilot
This article was originally published in Scrip
Executive Summary
The European pharmaceutical industry association, EFPIA, today launched its anticounterfeiting pilot project in Sweden, raising concerns among parallel traders that should it be rolled out across the EU, the scheme's central database may be misused by manufacturers to curb sales to certain wholesalers.